We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Risk Factors Identified for Little-Known Lung Infections

By LabMedica International staff writers
Posted on 25 Mar 2014
Severe and sometimes fatal lung disease caused by a group of bacteria in the same family as those that cause tuberculosis is much more common than previously thought.

Nontuberculous mycobacteria (NTM) include more than 150 types of bacteria found in water and soil that can infect the lungs when inhaled, but unlike tuberculosis, NTM is not contagious and cannot spread from person to person.

Scientists at the University of Illinois (Chicago, IL, USA) analyzed mortality related to nontuberculous mycobacterial infections from 1999 through 2010 by examining multiple-cause-of-death data from the National Center for Health Statistics (Atlanta, GA, USA). More...
They analyzed age-adjusted mortality rates, trends, associations with demographic variables, and comorbid conditions and correlated this information with similar data for tuberculosis-related mortality during the same time.

The investigators found that NTM was listed as immediate cause of death for 2,990 people, of whom 87% were 55 or older, 85% were white, and 52% were female. NTM-related deaths also correlated with smoking, cancer, human immunodeficiency virus (HIV) infection, and chronic obstructive pulmonary disease. They also found that the age-adjusted NTM mortality rates were uneven across the USA. Tuberculosis-related deaths among ethnic groups were also disproportional as among those with tuberculosis, 4,847 (59%) were white.

The team suggested that both warm and dry climates may contribute to NTM disease and influence on mortality by different environmental factors, such as temperature, soil and water conditions. NTM demonstrated a strong relationship with some comorbid conditions such as chronic obstructive pulmonary disease, chronic respiratory failure, bronchiectasis, HIV, interstitial lung diseases, rheumatoid arthritis, hematopoietic malignancies and tobacco use. The infection is treatable, but antibiotic therapy is expensive and can take up to two years. Examples of nontuberculous mycobacteria that should be distinguished from tubercle bacilli are Mycobacterium chelonae, M. abscessus, M. fortuitum, and M. cosmeticum

Mehdi Mirsaeidi, MD, MPH, the lead author said, “People and physicians need to be aware of NTM, especially as we see more of it, and because it can look like a lot of other pulmonary diseases. Patients usually present with a cough, and correct diagnosis can take years. Having a better understanding of the risk factors associated with NTM will give us a better chance of diagnosing it faster. This is important, because it's largely a curable infection.” The study was published on March 14, 2014, in the journal Public Library of Science ONE.

Related Links:

University of Illinois
National Center for Health Statistics



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Automated Urinalysis Solution
UN-9000
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers found that tumor DNA fragments in blood can reveal ongoing prostate cancer growth even when current tests show little change (image credit: Adobe Stock)

Blood Test Detects Early Nonresponse in Metastatic Prostate Cancer

Prostate cancer is the most common cancer in the U.K., with more than 64,000 men diagnosed and 12,000 deaths each year. For the roughly 10,000 men annually with advanced disease, early assessment of treatment... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.